Applied Clinical Trials
Examining the unique standards and related challenges when assessing the safety and efficacy of cancer immunotherapy candidates.
Luke S. Gill
Advertisement
Articles by Luke S. Gill
Applied Clinical Trials
Cancer immunotherapies require different standards for evaluating their safety and effectiveness. Understanding these standards-and the other major challenges of immuno-oncology studies-is critical to drug development success.
Advertisement
Latest Updated Articles
Maximizing Immuno-Oncology Clinical Trial SuccessApril 5th 2018
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Site Readiness for Cell and Gene Therapies: Operational and Supply Chain Challenges as they Scale and as they Expand into the Community Care Setting
2
Moving Beyond Disappointing Pilots: Scaling Adoption of AI-Enablement in Drug Development
3
ACT Brief: Data Provenance and Device Strategy, Cell-Gene Therapy Site Readiness, and Data Harmonization Bottleneck
4
Beyond Compliance: Vivalink's Cecilia Xi, PhD, on Data Provenance and Sustainable Device Strategy in Clinical Trials
5